Samsara BioCapital’s Astria Therapeutics ATXS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$208K	–	42
2023 Q2	$208K	Hold	25,000	–	–	0.04%	42
2023 Q1	$333K	Hold	25,000	–	–	0.07%	44
2022 Q4	$372K	Hold	25,000	–	–	0.08%	47
2022 Q3	$226K	Hold	25,000	–	–	0.05%	51
2022 Q2	$75K	Hold	25,000	–	–	0.02%	54
2022 Q1	$168K	Hold	25,000	–	–	0.04%	55
2021 Q4	$135K	Hold	25,000	–	–	0.03%	48
2021 Q3	$221K	Hold	25,000	–	–	0.03%	45
2021 Q2	$317K	Hold	25,000	–	–	0.04%	47
2021 Q1	$434K	Sell	25,000 -25,000	-50%	-$434K	0.08%	41
2020 Q4	$642	Hold	50,000	–	–	0.06%	41
2020 Q3	$1.86M	Hold	50,000	–	–	0.52%	29
2020 Q2	$1.93M	Hold	50,000	–	–	0.62%	25
2020 Q1	$1.25M	Hold	50,000	–	–	0.72%	23
2019 Q4	$1.77M	Hold	50,000	–	–	0.85%	19
2019 Q3	$1.62M	Hold	50,000	–	–	1.1%	13
2019 Q2	$2.42M	Hold	50,000	–	–	1.6%	13
2019 Q1	$2.38M	Hold	50,000	–	–	1.87%	12
2018 Q4	$1.31M	Buy	+50,000	New	+$1.31M	1.26%	12